Sleep Intervention + CBT for Insomnia
CS
Overseen byCatherine Siengsukon, PT, PhD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: University of Kansas Medical Center
No Placebo Group
Trial Summary
What is the purpose of this trial?
This trial tests a sleep improvement program for older adults with insomnia. It aims to see if better sleep can enhance memory and reduce brain changes related to Alzheimer's disease.
Research Team
CS
Catherine Siengsukon, PT, PhD
Principal Investigator
University of Kansas Medical Center
Eligibility Criteria
Adults aged 60-85 with insomnia symptoms, who have trouble sleeping at least three nights a week for six months and score high enough on mental state exams to show no severe cognitive impairment or dementia. Excluded are those with untreated sleep disorders, severe depression, substance abuse history, certain mental illnesses or learning disabilities, current shift workers, or those already in CBT-I treatment.Inclusion Criteria
I have had trouble sleeping at least three nights a week for the past six months.
You have a score of 10 or more on the Insomnia Severity Index.
You have a score of 25 or higher on the Mini-Mental State Examination (MMSE).
See 3 more
Exclusion Criteria
You have had trouble learning or paying attention in the past.
I am currently taking medication or supplements for sleep problems.
I have an untreated sleep disorder like sleep apnea or restless leg syndrome.
See 8 more
Treatment Details
Interventions
- Cognitive Behavioral Therapy for Insomnia (CBT-I) (Behavioral Intervention)
- Sleep and Lifestyle Education (Behavioral Intervention)
Trial OverviewThe trial is testing whether a six-week program of Sleep and Lifestyle Education combined with Cognitive Behavioral Therapy for Insomnia (CBT-I) can improve cognitive function and reduce brain amyloid deposits in older adults with insomnia. Some participants will also undergo PET imaging to track changes in amyloid levels over one year.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Six-Week CBT-I ProgramExperimental Treatment1 Intervention
CBT-I, six sessions, forty-five to sixty minutes in duration.
Session 1: set up sleep restriction and stimulus control, discuss strategies for how to stay awake to a prescribed hour and what to do with wake after onset sleep time, provide sleep hygiene education.
Session 2: determine if upward titration of total sleep time is warranted, review sleep hygiene.
Session 3: continue upward titration of total sleep time, cognitive therapy for negative sleep beliefs if indicated.
Session 4: continue upward titration of total sleep time, follow-up regarding negative sleep beliefs.
Session 5: continue upward titration of total sleep time, discuss relapse prevention.
Session 6: assess global treatment gains, discuss questions regarding relapse prevention.
Group II: Six-Week Sleep and Lifestyle Education ProgramActive Control1 Intervention
Sleep and Lifestyle Education, six sessions, forty-five to sixty minutes in duration.
Session 1: Sleep education, Instruction/demonstration on stretching exercises.
Session 2: Education on environmental factors \& sleeping positions that impact sleep.
Session 3: Education on lifestyle factors that impact sleep.
Session 4: Education on diet and sleep.
Session 5: Education on exercises and sleep.
Session 6: Discus maintaining achievements \& preventing relapses.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Kansas Medical Center
Lead Sponsor
Trials
527
Recruited
181,000+
National Institute on Aging (NIA)
Collaborator
Trials
1,841
Recruited
28,150,000+
National Institutes of Health (NIH)
Collaborator
Trials
2,896
Recruited
8,053,000+